A new study says the early U.S. COVID-19 death toll is much higher than official counts, and that there were disparities in ...

There was a doctor in Chicago years ago named Victor Frankenstein, and one of his jobs was finding medical specimens. When ...

Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets while developing a diverse pipeline of novel, multifunctional biotherapeutics, today announced ...

Shrinking Season 3 Episode 8 ending explained. Why Gaby rejects Paul, Maya’s death impact, and Jimmy-Sofi relationship update.

The woman alleges that Prudential "manipulated" the language of the contract "with the sole purpose to make financial gains", ...

Akari Therapeutics is an oncology biotechnology company developing next-generation antibody drug conjugates (ADCs) with a unique payload, PH1, which targets RNA splicing. Utilizing its innovative ADC ...

On track to complete enrollment for the Phase 3 PROACT 1 accelerated approval analysis of rilparencel in mid-2026; anticipate ...

Aerolib launches Aerolib.app for Physician Advisors, featuring P2P simulations, IP-only search tools, & real-time ...

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company and its partners will present one oral and six poster presentations at the 2026 American Association for Cancer Research (AACR) ...

COVID may have killed significantly more people in the U.S. in the first two years of the pandemic than official records indicate, with as many as one overlooked death for every five recorded ones.

The global cell and gene therapy market is forecast to surge from $10.4 billion to more than $45 billion by 2035, with over 40 FDA-approved products and North America commandi ...

Issued on behalf of Avaí Bio, Inc. VANCOUVER, BC, March 18, 2026 /CNW/ — Equity-Insider.com — There is a key “master” protein in your body called α-Klotho. You’ve probably never heard of it.